Prosthetic heart valve thrombosis: Diagnosis and newer thrombolytic regimes

Prosthetic heart valve thrombosis incidence is high in developing countries and contributes to significant late mortality postvalve surgery. Many guidelines advocate surgery as the first line therapy though thrombolysis is often used in many centers. In this article, we review the newer regimens of...

Full description

Bibliographic Details
Main Author: Shanmugam Krishnan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Journal of the Practice of Cardiovascular Sciences
Subjects:
Online Access:http://www.j-pcs.org/article.asp?issn=2395-5414;year=2016;volume=2;issue=1;spage=7;epage=12;aulast=Krishnan
_version_ 1811213952175046656
author Shanmugam Krishnan
author_facet Shanmugam Krishnan
author_sort Shanmugam Krishnan
collection DOAJ
description Prosthetic heart valve thrombosis incidence is high in developing countries and contributes to significant late mortality postvalve surgery. Many guidelines advocate surgery as the first line therapy though thrombolysis is often used in many centers. In this article, we review the newer regimens of fibrin-specific thrombolytics. Newer regimens of very low-dose, slow infusion lead to equal efficacy with lower complication in majority of patients. Patients with the New York Heart Association (NYHA) Class I–II who have low thrombus burden should receive thrombolysis with low-dose slow infusion while those with high thrombus burden should be planned for surgery. Patients presenting with NYHA Class IV should be treated with classical dose thrombolysis.
first_indexed 2024-04-12T05:54:49Z
format Article
id doaj.art-5ac51bc7bd6c4ca8bf697ed61359876d
institution Directory Open Access Journal
issn 2395-5414
2454-2830
language English
last_indexed 2024-04-12T05:54:49Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of the Practice of Cardiovascular Sciences
spelling doaj.art-5ac51bc7bd6c4ca8bf697ed61359876d2022-12-22T03:45:10ZengWolters Kluwer Medknow PublicationsJournal of the Practice of Cardiovascular Sciences2395-54142454-28302016-01-012171210.4103/2395-5414.182993Prosthetic heart valve thrombosis: Diagnosis and newer thrombolytic regimesShanmugam KrishnanProsthetic heart valve thrombosis incidence is high in developing countries and contributes to significant late mortality postvalve surgery. Many guidelines advocate surgery as the first line therapy though thrombolysis is often used in many centers. In this article, we review the newer regimens of fibrin-specific thrombolytics. Newer regimens of very low-dose, slow infusion lead to equal efficacy with lower complication in majority of patients. Patients with the New York Heart Association (NYHA) Class I–II who have low thrombus burden should receive thrombolysis with low-dose slow infusion while those with high thrombus burden should be planned for surgery. Patients presenting with NYHA Class IV should be treated with classical dose thrombolysis.http://www.j-pcs.org/article.asp?issn=2395-5414;year=2016;volume=2;issue=1;spage=7;epage=12;aulast=KrishnanProsthetic heart valve thrombosisstreptokinasethrombolysistissue plasminogen activator
spellingShingle Shanmugam Krishnan
Prosthetic heart valve thrombosis: Diagnosis and newer thrombolytic regimes
Journal of the Practice of Cardiovascular Sciences
Prosthetic heart valve thrombosis
streptokinase
thrombolysis
tissue plasminogen activator
title Prosthetic heart valve thrombosis: Diagnosis and newer thrombolytic regimes
title_full Prosthetic heart valve thrombosis: Diagnosis and newer thrombolytic regimes
title_fullStr Prosthetic heart valve thrombosis: Diagnosis and newer thrombolytic regimes
title_full_unstemmed Prosthetic heart valve thrombosis: Diagnosis and newer thrombolytic regimes
title_short Prosthetic heart valve thrombosis: Diagnosis and newer thrombolytic regimes
title_sort prosthetic heart valve thrombosis diagnosis and newer thrombolytic regimes
topic Prosthetic heart valve thrombosis
streptokinase
thrombolysis
tissue plasminogen activator
url http://www.j-pcs.org/article.asp?issn=2395-5414;year=2016;volume=2;issue=1;spage=7;epage=12;aulast=Krishnan
work_keys_str_mv AT shanmugamkrishnan prostheticheartvalvethrombosisdiagnosisandnewerthrombolyticregimes